Zai Lab Limited
ZLABNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $2.72B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $15.96$29.77
- Volume (live)
- -
- Avg. volume (3M)
- 954.85K
Zai Lab (ZLAB) Stock Price & Financial Analysis
Zai Lab Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $22.44 - $23.81 |
|---|---|
| 52-Week High | $29.77 |
| 52-Week Low | $15.96 |
| Open | $23.10 |
| Volume (last close) | 1.54M |
| Average Volume (3M) | 954.85K |
| Revenue (TTM) | 449.61M |
|---|---|
| Net Income (TTM) | -188.21M |
| Free Cash Flow (TTM) | -162.37M |
| EPS (TTM) | −$1.70 |
| Profit Margin | -41.86% |
| Operating Margin | -58.53% |
| Return on Equity (ROE) | -31.01% |
| Debt to Equity | 0.41 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.72B |
|---|---|
| Shares Outstanding | 111.70M |
| Price to Sales (P/S) | 6.05 |
| Price to Book (P/B) | 4.48 |
| EV/EBITDA | -10.79 |
| 50-Day MA | $25.37 |
|---|---|
| 200-Day MA | $20.80 |
| 1-Year Change | −21.34% |
Source: Market prices and company fundamentals. Data as of Oct 27, 2026. Data sources and methodology
Zai Lab at a Glance
As of the Oct 27, 2026 close, Zai Lab (ZLAB) has a market capitalization of $2.72B. The stock trades at 6.0× sales. Over the trailing twelve months it lost $188.21M on revenue of $449.61M and burned $162.37M of free cash flow. Revenue grew 5.1% year over year.
As of its latest reported balance sheet, it holds $607.52M in cash and securities against $249.55M of debt, a net cash position of $357.97M.
Zai Lab does not currently pay a dividend.
The share price is down 21.3% over the past year. At $23.58 (the Oct 27, 2026 close) it sits within its 52-week range of $15.96 to $29.77, above its 200-day moving average of $20.80.
Based on 3 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $39.33, 66.8% above the Oct 27, 2026 close.
Frequently Asked Questions About Zai Lab
What is the current stock price for ZLAB?
As of the Oct 27, 2026 close, ZLAB stock trades at $23.58. The 52-week range is $15.96–$29.77, with a day range of $22.44–$23.81.
What is the P/E ratio for ZLAB?
The P/E ratio (Price-to-Earnings) for ZLAB is shown in the Key Statistics section. This valuation metric helps compare Zai Lab Limited to industry peers.
Does ZLAB pay dividends?
Zai Lab does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ZLAB?
Based on ratings from 3 professional analysts over the last 90 days, the consensus for ZLAB is Buy. The average 12-month price target is $39.33, a 66.8% upside from the Oct 27, 2026 close of $23.58.
What is the market cap of ZLAB?
As of the Oct 27, 2026 close, Zai Lab's market capitalization is $2.63B, classifying it as a mid-cap company. Zai Lab operates in the Healthcare sector within the Biotechnology industry.